Orgul Ozturk1, Yuan Hong2, Suzanne McDermott3, Margaret Turk4. 1. Economics Department, Darla Moore School of Business, University of South Carolina, Columbia, 803-4636168, USA. odozturk@moore.sc.edu. 2. Department of Epidemiology and Biostatistics Arnold School of Public Health, University of South Carolina University of South Carolina, Columbia, USA. 3. Department of Environmental, Occupational, and Geospatial Health Sciences, School of Public Health and Health Policy, City University of New York, New York, USA. 4. Department of Physical Medicine and Rehabilitation, Upstate Medical University, Syracuse, USA.
Abstract
BACKGROUND: There are variants of prescription drug monitoring programs (PDMPs) and different groups of patients who are prescribed opioids. Patients with disabilities and those with chronic conditions might have different experiences in physician prescribing practices for opioids, when compared to a comparison group without these conditions. OBJECTIVE: To determine differences in opioid prescriptions related to PDMPs for people without cancer-related pain and with disability conditions compared to other adult opioid users without cancer, using a national database. METHOD: Opioid users were identified from the US Medical Expenditure Panel Survey. Disability groups were defined by diagnosis codes related to longstanding physical disability and inflammatory conditions. Our analyses used an event study framework and a difference-in-differences approach. RESULTS: During a two-year panel period, PDMPs did not reduce opioid prescriptions for individuals with disabilities who use opioids. Our data show that individuals with disabilities who use opioids, on average, have a higher incidence of continuous opioid use and significantly greater amounts prescribed compared to other adults who have opioid prescriptions. CONCLUSION: PDMPs do not appear to affect prescribers' initial or ongoing use of opioids for individuals with longstanding physical disabilities and those with inflammatory conditions. Thus, these adults have greater exposure to opioids, compared to other adults who were prescribed opioids.
BACKGROUND: There are variants of prescription drug monitoring programs (PDMPs) and different groups of patients who are prescribed opioids. Patients with disabilities and those with chronic conditions might have different experiences in physician prescribing practices for opioids, when compared to a comparison group without these conditions. OBJECTIVE: To determine differences in opioid prescriptions related to PDMPs for people without cancer-related pain and with disability conditions compared to other adult opioid users without cancer, using a national database. METHOD: Opioid users were identified from the US Medical Expenditure Panel Survey. Disability groups were defined by diagnosis codes related to longstanding physical disability and inflammatory conditions. Our analyses used an event study framework and a difference-in-differences approach. RESULTS: During a two-year panel period, PDMPs did not reduce opioid prescriptions for individuals with disabilities who use opioids. Our data show that individuals with disabilities who use opioids, on average, have a higher incidence of continuous opioid use and significantly greater amounts prescribed compared to other adults who have opioid prescriptions. CONCLUSION: PDMPs do not appear to affect prescribers' initial or ongoing use of opioids for individuals with longstanding physical disabilities and those with inflammatory conditions. Thus, these adults have greater exposure to opioids, compared to other adults who were prescribed opioids.
Authors: Joanne E Brady; Hannah Wunsch; Charles DiMaggio; Barbara H Lang; James Giglio; Guohua Li Journal: Public Health Rep Date: 2014 Mar-Apr Impact factor: 2.792
Authors: Roger Chou; Judith A Turner; Emily B Devine; Ryan N Hansen; Sean D Sullivan; Ian Blazina; Tracy Dana; Christina Bougatsos; Richard A Deyo Journal: Ann Intern Med Date: 2015-02-17 Impact factor: 25.391
Authors: Liza M Reifler; Danna Droz; J Elise Bailey; Sidney H Schnoll; Reginald Fant; Richard C Dart; Becki Bucher Bartelson Journal: Pain Med Date: 2012-02-02 Impact factor: 3.750
Authors: Lainie Rutkow; Hsien-Yen Chang; Matthew Daubresse; Daniel W Webster; Elizabeth A Stuart; G Caleb Alexander Journal: JAMA Intern Med Date: 2015-10 Impact factor: 21.873
Authors: Ellen Meara; Jill R Horwitz; Wilson Powell; Lynn McClelland; Weiping Zhou; A James O'Malley; Nancy E Morden Journal: N Engl J Med Date: 2016-06-22 Impact factor: 91.245
Authors: Gery P Guy; Kun Zhang; Michele K Bohm; Jan Losby; Brian Lewis; Randall Young; Louise B Murphy; Deborah Dowell Journal: MMWR Morb Mortal Wkly Rep Date: 2017-07-07 Impact factor: 17.586